Turner Jenkins
Profile
Mr. Turner Jenkins is Investment Analyst at A.
M.
Pappas & Associates LLC.
Prior to joining Pappas in August 2008, as a consultant, Mr. Jenkins performed supply chain risk assessment, business case analysis, and strategic planning for Amylin Pharmaceuticals, and he also has experience in financial modeling and developing go-to-market strategies for multiple biotech startups.
He previously worked as a polymer chemist for MediVas, LLC, for which he developed bioabsorbable amino acid based polymers used for controlled drug delivery applications.
He is a co-author of an American Chemical Society book chapter and an inventor on two patent applications.
Mr. Jenkins received a BS in Chemical Engineering with emphasis in Biomedical studies from UCLA, and an MBA from UC San Diego Rady School of Management.
Former positions of Turner Jenkins
Companies | Position | End |
---|---|---|
MediVas LLC
MediVas LLC Medical DistributorsDistribution Services MediVas LLC manufactured and developed drugs and biologics therapeutic devices. It provided a platform of biocompatible and biodegradable synthetic polymers for medicinal injection or implantation as drug delivery or tissue regeneration materials. The company was founded by Kenneth W. Carpenter and Paul S. Teirstein in 1998 and was headquartered in La Jolla, CA. | Corporate Officer/Principal | - |
OTONOMY | Corporate Officer/Principal | - |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Private Equity Analyst | - |
Training of Turner Jenkins
University of California, Los Angeles | Undergraduate Degree |
University of California San Diego | Masters Business Admin |
Experiences
Positions held
Linked companies
Private companies | 3 |
---|---|
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina. | Finance |
Otonomy, Inc.
Otonomy, Inc. BiotechnologyHealth Technology Otonomy, Inc. operates as a biopharmaceutical company. engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA. | Health Technology |
MediVas LLC
MediVas LLC Medical DistributorsDistribution Services MediVas LLC manufactured and developed drugs and biologics therapeutic devices. It provided a platform of biocompatible and biodegradable synthetic polymers for medicinal injection or implantation as drug delivery or tissue regeneration materials. The company was founded by Kenneth W. Carpenter and Paul S. Teirstein in 1998 and was headquartered in La Jolla, CA. | Distribution Services |
- Stock Market
- Insiders
- Turner Jenkins